Jennifer Z Cooper1, Marc D Brown. 1. Department of Dermatology, University of Maryland, Baltimore, MD 21201, USA. jzcooper@som.umaryland.edu
Abstract
BACKGROUND: Several risk factors are generally accepted to portend more aggressive behavior of cutaneous squamous cell carcinoma. These include tumor size, tumor depth, histologic subtype, location on the lip or ear, tumor arising in scar, recurrent tumor, and tumor demonstrating perineural invasion. Organ transplant recipients can have significant morbidity and mortality from squamous cell carcinoma. OBSERVATIONS: Four organ transplant recipients developed metastatic disease from squamous cell carcinoma of the scalp. CONCLUSIONS: Squamous cell carcinoma of the scalp in organ transplant recipients should be considered a high-risk tumor because of its anatomic location. Margin-controlled tumor extirpation, sentinel lymph node biopsy, and adjuvant radiation therapy should all be considered in the organ transplant recipient population.
BACKGROUND: Several risk factors are generally accepted to portend more aggressive behavior of cutaneous squamous cell carcinoma. These include tumor size, tumor depth, histologic subtype, location on the lip or ear, tumor arising in scar, recurrent tumor, and tumor demonstrating perineural invasion. Organ transplant recipients can have significant morbidity and mortality from squamous cell carcinoma. OBSERVATIONS: Four organ transplant recipients developed metastatic disease from squamous cell carcinoma of the scalp. CONCLUSIONS:Squamous cell carcinoma of the scalp in organ transplant recipients should be considered a high-risk tumor because of its anatomic location. Margin-controlled tumor extirpation, sentinel lymph node biopsy, and adjuvant radiation therapy should all be considered in the organ transplant recipient population.
Authors: Jerry D Brewer; Oscar R Colegio; P Kim Phillips; Randall K Roenigk; M Amanda Jacobs; Diederik Van de Beek; Ross A Dierkhising; Walter K Kremers; Christopher G A McGregor; Clark C Otley Journal: Arch Dermatol Date: 2009-12
Authors: Edit B Olasz; Lauren N Seline; Ashley M Schock; Nathan E Duncan; Argelia Lopez; Jozef Lazar; Michael J Flister; Yan Lu; Pengyuan Liu; Olayemi Sokumbi; Catherine A Harwood; Charlotte M Proby; Marcy Neuburg; Zelmira Lazarova Journal: PLoS One Date: 2015-05-04 Impact factor: 3.240
Authors: Montserrat Fernández-Guarino; José Javier Zamorano León; Antonio José López Farré; Maria Luisa González Morales; Ana Isabel Sánchez Adrada; José Barrio Garde; Jose Antonio Arias Navalon; Pedro Jaén Olasolo Journal: Cancers (Basel) Date: 2020-05-03 Impact factor: 6.639